HBL Market Share Analysis for November 2025

HBL, Pakistan's best largest bank, according to the Asiamoney HBL is the Best domestic, corporate and investment bank in the pakistan. HBL has grown its branch network to over 1,700 branches, +2,000 ATMs and serving 20 million customers in 15 countries.

Health > Biotechnology and Pharmaceuticals

Domainhbl.co.il

Year Founded1941

Employees> 10001

Annual Revenue$500M - $1B

HBL

HBL (including company regionals)

hbl.co.il

See more website traffic and engagement information

HBL Revenue up to November 2025 is 500M - 1B

revenue generated by HBL top domains

HBL top domains revenue over 3 years

Revenue for HBL top domains

hbl.co.il500M - 1B

See more with Sales Intelligence

Total visits to HBL's top domains

Understand HBL market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in HBL's top domains

Analyze HBL engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on HBL's top domains

See how HBL keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

HBL top competitors by domain

Top similar sites in November 2025, ranked by their affinity

pvct.comCompany NameProvectus PharmaceuticalsEmployees51 - 200HQUnited States, Tennessee, KnoxvilleAnnual revenue--Total visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by HBL

These are the website technologies, by industry, used by HBL top domains

Widget (3)

Twemoji

Content Management System (2)

WordPress

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

3

See all

News & Signals from HBL

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHbl invests into Enlivex Therapeutics Ltd. $8M.Korea Investment Partners (KIP) and Tel Aviv-listed biotechnology enterprise Hadasit Bio Holdings Ltd. have backed an $8 million equity investment in Enlivex Therapeutics Ltd., a clinical-stage immunotherapy company, at a valuation of approximately $50 million pre-closing.